Jiangxi Synergy Pharmaceutical Co., Ltd. (SHE:300636)
China · Delayed Price · Currency is CNY 8.15
+0.07 (0.87%)
Feb 4, 2026, 3:04 PM CST
SHE:300636 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 94.51 | 106.58 | 105.98 | 100.67 | 81.12 | 70.05 |
Depreciation & Amortization | 114.58 | 114.58 | 69.39 | 66.88 | 51.58 | 52.33 |
Other Amortization | 0.19 | 0.19 | - | - | - | - |
Loss (Gain) From Sale of Assets | 1.17 | 1.17 | 1.32 | 0.18 | 1.01 | 1.73 |
Asset Writedown & Restructuring Costs | - | - | - | - | -0.04 | -0.58 |
Loss (Gain) From Sale of Investments | -0.62 | -0.62 | -0.57 | 1.21 | -0.28 | -0.07 |
Provision & Write-off of Bad Debts | 1.27 | 1.27 | -0.11 | 1.48 | 2.11 | - |
Other Operating Activities | 82.87 | 39.78 | 22.96 | 15 | 10.48 | 9.55 |
Change in Accounts Receivable | -12.49 | -12.49 | 22.41 | -11.52 | -61.27 | 55.86 |
Change in Inventory | -55.66 | -55.66 | -45.2 | -131.24 | -42.8 | -97.33 |
Change in Accounts Payable | 100.72 | 100.72 | -23.01 | 133.01 | 85.34 | -19.25 |
Change in Other Net Operating Assets | -16.3 | -16.3 | 4.33 | 14.85 | -3.12 | -0.23 |
Operating Cash Flow | 316.21 | 285.19 | 163.75 | 196 | 131.34 | 80.07 |
Operating Cash Flow Growth | 43.61% | 74.16% | -16.45% | 49.23% | 64.04% | - |
Capital Expenditures | -340.81 | -136.49 | -214.65 | -311.49 | -424.67 | -229.99 |
Sale of Property, Plant & Equipment | 0.62 | 0.49 | 0.23 | 1.12 | 0.44 | 0.6 |
Investment in Securities | 323.71 | -370.33 | -493.96 | -30 | -20 | - |
Other Investing Activities | 0.14 | 0.68 | 2.18 | -1.61 | 0.02 | 0.07 |
Investing Cash Flow | -13.04 | -505.65 | -706.21 | -341.99 | -444.21 | -229.33 |
Long-Term Debt Issued | - | 870.49 | 924.7 | 391.74 | 427.46 | 733.15 |
Long-Term Debt Repaid | - | -937.36 | -770.72 | -285.68 | -211.16 | -303.08 |
Total Debt Repaid | -732.56 | -937.36 | -770.72 | -285.68 | -211.16 | -303.08 |
Net Debt Issued (Repaid) | -164.54 | -66.87 | 153.98 | 106.06 | 216.3 | 430.07 |
Issuance of Common Stock | - | - | 789.82 | 41.42 | - | - |
Repurchase of Common Stock | -12.98 | -12.98 | -0.43 | - | - | -9.69 |
Common Dividends Paid | -12.78 | -29.12 | -26.91 | -32.11 | -21.8 | -22.79 |
Other Financing Activities | 12.63 | -2 | 38.8 | -46.8 | -6.82 | 0.15 |
Financing Cash Flow | -177.67 | -110.97 | 955.26 | 68.57 | 187.68 | 397.75 |
Foreign Exchange Rate Adjustments | 0.69 | 4.05 | 1.82 | 1.13 | -0.74 | -4.12 |
Net Cash Flow | 126.19 | -327.39 | 414.62 | -76.29 | -125.93 | 244.37 |
Free Cash Flow | -24.6 | 148.7 | -50.9 | -115.5 | -293.33 | -149.93 |
Free Cash Flow Margin | -2.98% | 19.59% | -7.05% | -16.04% | -49.54% | -34.43% |
Free Cash Flow Per Share | -0.06 | 0.35 | -0.13 | -0.33 | -0.87 | -0.48 |
Cash Income Tax Paid | - | -27.75 | -41.2 | -84.82 | -59.22 | -48.55 |
Levered Free Cash Flow | -144.79 | 21 | -201.9 | -197.59 | -293.72 | -217.86 |
Unlevered Free Cash Flow | -135.72 | 32.34 | -195.72 | -192.78 | -290.16 | -212.24 |
Change in Working Capital | 22.24 | 22.24 | -35.23 | 10.57 | -14.64 | -52.94 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.